Investigation of the H+-myo-inositol transporter (HMIT) as a neuronal regulator of phosphoinositide signalling

Biochemical Society Transactions

Volumn 37, Issue 5, 2009, Pages 1139-1143

  Di Daniel, Elena ^a   Kew, James N ^a   Maycox, Pete R ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Bipolar disorder; H+ myo inositol transporter (HMIT); Myo inositol 1 phosphate synthase (MIP synthase); Phosphoinositide; Sodium myo inositol transporter (SMIT)

Indexed keywords

CARBAMAZEPINE; CARRIER PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE; LITHIUM SALT; MUNC18 PROTEIN; MYO INOSITOL TRANSPORTER; MYOINOSITOL 1 PHOSPHATE SYNTHASE; PHOSPHATIDYLINOSITIDE; SODIUM MYO INOSITOL TRANSPORTER; UNCLASSIFIED DRUG; VALPROIC ACID;

BIPOLAR DISORDER; CELL GROWTH; CELL STRUCTURE; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG MECHANISM; EXTRACELLULAR FLUID; GENE EXPRESSION; HUMAN; LIPID HYDROLYSIS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIMANIC AGENTS; BRAIN; CARBAMAZEPINE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; INOSITOL; LITHIUM COMPOUNDS; MEMBRANE TRANSPORT PROTEINS; NEURONS; PHOSPHATIDYLINOSITOLS; SIGNAL TRANSDUCTION; VALPROIC ACID;

EID: 70350157028     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0371139     Document Type: Conference Paper

References (51)

1. Moore, G.J., Bebchuk, J.M., Parrish, J.K., Faulk, M.W., Arfken, C.L., Strahl-Bevacqua, J. and Manji, H.K. (1999) Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am. J. Psychiatry 156, 1902-1908
2. Silverstone, P.H., Wu, R.H., O'Donnell, T., Ulrich, M., Asghar, S.J. and Hanstock, C.C. (2002) Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients. Hum. Psychopharmacol. 17, 321-327
3. McLaughlin, S. and Murray, D. (2005) Plasma membrane phosphoinositide organization by protein electrostatics. Nature 438, 605-611
4. Micheva, K.D., Holz, R.W. and Smith, S.J. (2001) Regulation of presynaptic phosphatidylinositol 4,5-biphosphate by neuronal activity. J. Cell Biol. 154, 355-368
5. Osborne, S.L., Meunier, F.A. and Schiavo, G. (2001) Phosphoinositides as key regulators of synaptic function. Neuron 32, 9-12
6. Bennett, M., Onnebo, S.M., Azevedo, C. and Saiardi, A. (2006) Inositol pyrophosphates: metabolism and signaling. Cell. Mol. Life Sci. 63, 552-564
7. Berridge, M.J. and Irvine, R.F. (1989) Inositol phosphates and cell signalling. Nature 341, 197-205
8. Irvine, R.F., Lloyd-Burton, S.M., Yu, J.C., Letcher, A.J. and Schell, M.J. (2006) The regulation and function of inositol 1,4,5-trisphosphate 3-kinases. Adv. Enzyme Regul. 46, 314-323
9. Heacock, A.M. and Agranoff, B.W. (1997) CDP-diacylglycerol synthase from mammalian tissues. Biochim. Biophys. Acta 1348, 166-172
10. 2-mediated signalling in human disease. Trends Pharmacol. Sci. 26, 654-660
11. Cockcroft, S. (2001) Phosphatidylinositol transfer proteins couple lipid transport to phosphoinositide synthesis. Semin. Cell Dev. Biol. 12, 183-191
12. Williams, R.S., Cheng, L., Mudge, A.W. and Harwood, A.J. (2002) A common mechanism of action for three mood-stabilizing drugs. Nature 417, 292-295
13. Di Daniel, E., Cheng, L., Maycox, P.R. and Mudge, A.W. (2006) The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters. Mol. Cell. Neurosci. 32, 27-36
14. Allison, J.H. and Stewart, M.A. (1971) Reduced brain inositol in lithium-treated rats. Nat. New Biol. 233, 267-268
15. Hallcher, L.M. and Sherman, W.R. (1980) The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J. Biol. Chem. 255, 10896-10901
16. Bowden, C.L. (1996) Dosing strategies and time course of response to antimanic drugs. J. Clin. Psychiatry 57 (Suppl. 13), 4-9
17. Atack, J.R., Broughton, H.B. and Pollack, S.J. (1995) Structure and mechanism of inositol monophosphatase. FEBS Lett. 361, 1-7
18. Shamir, A., Sjoholt, G., Ebstein, R.P., Agam, G. and Steen, V.M. (2001) Characterization of two genes, Impa1 and Impa2 encoding mouse myo-inositol monophosphatases. Gene 271, 285-291
19. Agam, G., Shamir, A., Shaltiel, G. and Greenberg, M.L. (2002) Myo-inositol-1-phosphate (MIP) synthase: a possible new target for antibipolar drugs. Bipolar Disord. 4 (Suppl. 1), 15-20
20. Gee, N.S., Ragan, C.I., Watling, K.J., Aspley, S., Jackson, R.G., Reid, G.G., Gani, D. and Shute, J.K. (1988) The purification and properties of myo-inositol monophosphatase from bovine brain. Biochem. J. 249, 883-889
21. Parthasarathy, L., Vadnal, R.E., Parthasarathy, R. and Devi, C.S. (1994) Biochemical and molecular properties of lithium-sensitive myo-inositol monophosphatase. Life Sci. 54, 1127-1142
22. +-sensitive enzymes and proceeds via inositol 4-phosphate. Biochem. J. 249, 143-148
23. Nahorski, S.R., Ragan, C.I. and Challiss, R.A.J. (1991) Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences. Trends Pharmacol. Sci. 12, 297-303
24. Berridge, M.J., Downes, C.P. and Hanley, M.R. (1989) Neural and developmental actions of lithium: a unifying hypothesis. Cell 59, 411-419
25. +. J. Neurochem. 65, 2279-2289
26. Agranoff, B.W. and Fisher, S.K. (2001) Inositol, lithium, and the brain. Psychopharmacol. Bull. 35, 5-18
27. Shetty, H.U., Holloway, H.W. and Rapoport, S.I. (1995) Capillary gas chromatography combined with ion trap detection for quantitative profiling of polyols in cerebrospinal fluid and plasma. Anal. Biochem. 224, 279-285
28. Murray, M. and Greenberg, M.L. (2000) Expression of yeast INM1 encoding inositol monophosphatase is regulated by inositol, carbon source and growth stage and is decreased by lithium and valproate. Mol. Microbiol. 36, 651-661
29. Vadnal, R. and Parthasarathy, R. (1995) Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate. Neuropsychopharmacology 12, 277-285
30. Vaden, D.L., Ding, D., Peterson, B. and Greenberg, M.L. (2001) Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis. J. Biol. Chem. 276, 15466-15471
31. Shaltiel, G., Shamir, A., Shapiro, J., Ding, D., Dalton, E., Bialer, M., Harwood, A.J., Belmaker, R.H., Greenberg, M.L. and Agam, G. (2004) Valproate decreases inositol biosynthesis. Biol. Psychiatry 56, 868-874
32. Ju, S., Shaltiel, G., Shamir, A., Agam, G. and Greenberg, M.L. (2004) Human 1-D-myo-inositol-3-phosphate synthase is functional in yeast. J. Biol. Chem. 279, 21759-21765
33. Wong, Y.H., Kalmbach, S.J., Hartman, B.K. and Sherman, W.R. (1987) Immunohistochemical staining and enzyme activity measurements show myo-inositol-1-phosphate synthase to be localized in the vasculature of brain. J. Neurochem. 48, 1434-1442
34. van Calker, D. and Belmaker, R.H. (2000) The high affinity inositol transport system: implications for the pathophysiology and treatment of bipolar disorder. Bipolar Disord. 2, 102-107
35. Lubrich, B. and van Calker, D. (1999) Inhibition of the high affinity myo-inositol transport system: a common mechanism of action of antibipolar drugs? Neuropsychopharmacology 21, 519-529
36. Willmroth, F., Drieling, T., Lamla, U., Marcushen, M., Wark, H.J. and van Calker, D. (2006) Sodium-myo-inositol co-transporter (SMIT-1) mRNA is increased in neutrophils of patients with bipolar 1 disorder and down-regulated under treatment with mood stabilizers. Int. J. Neuropsychopharmacol. 10, 1-9
37. +/ myo-inositol cotransporter gene expression. Mol. Brain Res. 51, 91-96
38. Maallem, S., Berod, A., Mutin, M., Kwon, H.M. and Tappaz, M.L. (2006) Large discrepancies in cellular distribution of the tonicity-induced expression of osmoprotective genes and their regulatory transcription factor TonEBP in rat brain. Neuroscience 142, 355-368
39. +/myo-inositol cotransporter in rat kidney. J. Clin. Invest. 96, 1195-1201
40. Kitamura, H., Yamauchi, A., Sugiura, T., Matsuoka, Y., Horio, M., Tohyama, M., Shimada, S., Imai, E. and Hori, M. (1998) Inhibition of myo-inositol transport causes acute renal failure with selective medullary injury in the rat. Kidney Int. 53, 146-153
41. +/myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea. J. Biol. Chem. 278, 18297-18302
42. Chau, J.F., Lee, M.K., Law, J.W., Chung, S.K. and Chung, S.S. (2005) Sodium/myo-inositol cotransporter-1 is essential for the development and function of the peripheral nerves. FASEB J. 19, 1887-1889
43. Shaldubina, A., Buccafusca, R., Johanson, R.A., Agam, G., Belmaker, R.H., Berry, G.T. and Bersudsky, Y. (2007) Behavioural phenotyping of sodium-myo-inositol cotransporter heterozygous knockout mice with reduced brain inositol. Genes Brain Behav. 6, 253-259
44. Shaldubina, A., Johanson, R.A., O'Brien, W.T., Buccafusca, R., Agam, G., Belmaker, R.H., Klein, P.S., Bersudsky, Y. and Berry, G.T. (2006) SMIT1 haploinsufficiency causes brain inositol deficiency without affecting lithium-sensitive behavior. Mol. Genet. Metab 88, 384-388
45. Bersudsky, Y., Shaldubina, A., Agam, G., Berry, G.T. and Belmaker, R.H. (2008) Homozygote inositol transporter knockout mice show a lithium-like phenotype. Bipolar Disord. 10, 453-459
46. +/myo-inositol cotransporter. J. Biol. Chem. 277, 35219-35224
47. Bissonnette, P., Coady, M.J. and Lapointe, J.Y. (2004) Expression of the sodium-myo-inositol cotransporter SMIT2 at the apical membrane of Madin-Darby canine kidney cells. J. Physiol. 558, 759-768
48. +-myo-inositol symporter expressed predominantly in the brain. EMBO J. 20, 4467-4477
49. +/ myo-inositol symporter at synapses and growth cones. EMBO J. 23, 531-540
50. Cheng, L., Lumb, M., Polgar, L. and Mudge, A.W. (2005) How can the mood stabilizer VPA limit both mania and depression? Mol. Cell. Neurosci. 29, 155-161
51. Fisher, S.K., Novak, J.E. and Agranoff, B.W. (2002) Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J. Neurochem. 82, 736-754